Cargando…

Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group.

Detalles Bibliográficos
Autores principales: Eisenhauer, E. A., Silver, H. K., Venner, P. M., Thirlwell, M. P., Weinerman, B., Coppin, C. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1987
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001718/
https://www.ncbi.nlm.nih.gov/pubmed/3606945